More than $61 billion has flowed into the data center market so far this year. Hyperscalers are increasingly turning to outside capital in the form of debt to fund the energy-intensive infrastructure.

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...

Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

AI is transforming industries, fueling innovation, and addressing some of society’s most urgent challenges. From humanoid robotics to drought management, AI’s promise can feel boundless. Yet as demand ...

In June, Business Insider published an investigation into the data center industry. We wanted to dig into the pace of growth in light of the artificial intelligence boom, as well as the resources the ...

A controlled test compared three nearly identical pages: one with strong schema, one with poor schema, and one with none. Only the page with well-implemented schema appeared in an AI Overview and ...

TORONTO--(BUSINESS WIRE)--Structure Research, a leading independent research firm focused on cloud and data centre infrastructure, has released its latest reports: the Kuala Lumpur DCAI Report 2025: ...